Home / Tech News / English tech news

· 1 view · English tech news

World’s First Dual-Console 5-Arm Robotic Beating-Heart Bypass Performed in India at Medanta Gurugram

A New Chapter in Heart Surgery: Operating While the Heart Keeps Beating

On 18 November 2026, surgeons at Medanta Hospital in Gurugram achieved something never done before anywhere in the world. Two expert cardiac surgeons sat at separate control consoles and simultaneously guided five robotic arms to perform a complex coronary artery bypass on a patient’s heart that continued beating throughout the procedure.

The surgery, known as Totally Endoscopic Coronary Artery Bypass (TECAB), was carried out through tiny keyhole incisions. There was no large cut through the breastbone (sternotomy), no heart-lung machine, and significantly less blood loss. The patient’s recovery over the following 15 days was described as encouraging.

This is more than a technical achievement. It shows how Indian innovation is making advanced, less traumatic heart surgery more precise, collaborative, and potentially more affordable.

How Two Surgeons and Five Robotic Arms Worked in Perfect Sync

Traditional open-heart bypass requires a long incision, sawing through the sternum, and often stopping the heart with the help of a heart-lung machine. In this procedure:

  • Small ports were used for completely endoscopic access.
  • A specialised heart stabilisation system kept the target area steady while the heart continued to beat naturally.
  • Two surgeons operated at the same time from dual consoles of the SSI Mantra Surgical Robotic System (developed by SS Innovations International).
  • All five robotic arms were controlled in coordination.

In conventional surgery, one surgeon often has to assist by holding tissue or providing exposure. Here, both surgeons could actively operate instruments together, improving precision and also serving as real-time training for complex robotic cardiac work.

The operating team was led by Dr Nitin Kumar Rajput (Associate Director, Robotic and Minimally Invasive Cardiac Surgery, Medanta) and Dr Lalit Malik (Chief Cardiac Surgeon, Manipal Hospital, Jaipur), under the supervision of Dr Sudhir Srivastava, Founder, Chairman and CEO of SS Innovations International — widely regarded as a pioneer and “father” of robotic surgery in India.

The Vision Behind the Milestone: Make in India, for the World

Dr Sudhir Srivastava, who earlier performed hundreds of robotic cardiac procedures (including early beating-heart TECAB cases) in the United States before returning to India, has long championed affordable indigenous robotics.

He stated that the procedure demonstrated the capabilities of the SSI Mantra system and aligned with the company’s vision of “Make in India, for the World” — bringing advanced robotic surgery within reach of more patients and hospitals by reducing cost barriers compared with imported systems.

Dr Naresh Trehan, Chairman and Managing Director of Medanta, noted that such technology shows how complex cardiac procedures can be performed in a less invasive way. The dual-console design also allows a second surgeon to gain hands-on experience during high-end cases.

Patient Benefits of Robotic Beating-Heart TECAB

Compared with conventional bypass surgery, this approach offers:

  • No sternotomy (chest bone is not cut)
  • Smaller incisions and less tissue trauma
  • Avoidance of the heart-lung machine
  • Lower blood loss
  • Potentially quicker recovery and earlier return to normal activities (hospital and doctors reported encouraging progress within 15 days)
  • High-definition 3D visualisation and tremor-filtered precision from the robotic system

The SSI Mantra platform itself is modular (configurable with 3–5 arms), features an open-faced surgeon console with a large 3D 4K monitor, and supports a wide range of instruments across specialties. It has already been used in thousands of procedures globally and has strong telesurgery capabilities.

Why This Matters Beyond One Surgery

Robotic cardiac surgery has been growing in India, but high costs of foreign systems limited its spread. An indigenous system that can deliver world-first complexity at greater accessibility strengthens India’s position in medtech. It also expands training opportunities for surgeons and could gradually bring these benefits closer to more patients across the country and beyond.

This is not science fiction — it is a documented clinical milestone performed on 18 November 2026 at one of India’s leading hospitals using technology developed in India.

Source: EENADU.

Suggested